{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:07:36Z","timestamp":1791050856619,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jacl.2011.10.018","type":"journal-article","created":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T16:48:13Z","timestamp":1320425293000},"page":"5-18","source":"Crossref","is-referenced-by-count":227,"title":["Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review"],"prefix":"10.1016","volume":"6","author":[{"given":"Terry A.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara B.","family":"Glickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh N.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2011.10.018_bib1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjcard.2010.05.030","article-title":"30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006","volume":"106","author":"Cohen","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2011.10.018_bib2","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2011.10.018_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2007.11.008","article-title":"Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives","volume":"197","author":"Harris","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2011.10.018_bib4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2011.10.018_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2011.10.018_bib6","unstructured":"Lovaza\u00ae (omega-3-acid ethyl esters) [US full prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; 2009. Available at: http:\/\/us.gsk.com\/products\/assets\/us_lovaza.pdf. Accessed March 23, 2011."},{"key":"10.1016\/j.jacl.2011.10.018_bib7","unstructured":"Epadel\u00ae [Complete prescribing information]. Update (Version 5). Tokyo, Japan: Mochida Pharmaceutical; January 2007."},{"key":"10.1016\/j.jacl.2011.10.018_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00043798-199710000-00011","article-title":"Safety and efficacy of Omacor in severe hypertriglyceridemia","volume":"4","author":"Harris","year":"1997","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.jacl.2011.10.018_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0021-9150(98)00301-3","article-title":"Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins","volume":"143","author":"Pownall","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2011.10.018_bib10","unstructured":"Center for Drug Evaluation and Research. Approval Package for: 21-654 (Omacor\/Lovaza). Statistical Review; 2004. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/21-654_Omacor_AdminCorres_P1.pdf. Accessed June 24, 2011."},{"key":"10.1016\/j.jacl.2011.10.018_bib11","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2009.12.063","article-title":"Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to simvastatin therapy","volume":"105","author":"Maki","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2011.10.018_bib12","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.clinthera.2007.07.018","article-title":"Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g\/d to simvastatin 40 mg\/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study","volume":"29","author":"Davidson","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacl.2011.10.018_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1185\/03007991003645318","article-title":"Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients","volume":"26","author":"Bays","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacl.2011.10.018_bib14","unstructured":"Center for Drug Evaluation and Research. Application Number: 21-853, 21654s016, (Omacor). Statistical Review and Evaluation: Clinical Studies, Omacor (omega-3 acid ethyl ester) Capsules, 4 grams\/day; 2007. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2007\/021853s000;%20021654s016_StatR.pdf. Accessed June 24, 2011."},{"key":"10.1016\/j.jacl.2011.10.018_bib15","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2011.10.018_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2006.02.012","article-title":"Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review","volume":"189","author":"Balk","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2011.10.018_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOL.0b013e328321b3be","article-title":"Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes","volume":"20","author":"Hartweg","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2011.10.018_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.plefa.2009.05.004","article-title":"Toxicology and safety of DHA","volume":"81","author":"Lien","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jacl.2011.10.018_bib19","unstructured":"Haney EM, Huffman LH, Bougatsos C, et\u00a0al. Screening for lipid disorders in children and adolescents; Systematic evidence review for the U.S. Preventive Services Task Force (evidence synthesis). No. 47. Rockville, MD: Agency for Healthcare Research and Quality, US Department of Health and Human Services; AHRQ Publication No. 07-0598-EF-1; July 2007. Available at: http:\/\/www.uspreventiveservicestaskforce.org\/uspstf07\/chlipid\/chlipidsyn.pdf. Accessed March 23, 2011."},{"key":"10.1016\/j.jacl.2011.10.018_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2011.10.018_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3945\/jn.108.103861","article-title":"Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans","volume":"139","author":"Egert","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ajcn\/66.3.649","article-title":"Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids","volume":"66","author":"Grimsgaard","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/ajcn\/71.5.1085","article-title":"Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men","volume":"71","author":"Mori","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/76.2.326","article-title":"The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans","volume":"76","author":"Nestel","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M200282-JLR200","article-title":"Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance","volume":"44","author":"Park","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2011.10.018_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ajcn\/76.5.1007","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension","volume":"76","author":"Woodman","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib27","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.V10102177","article-title":"Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in\u00a0vivo peroxidation of LDL in dialysis patients","volume":"10","author":"Ando","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacl.2011.10.018_bib28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0029-7844(00)00988-1","article-title":"Eicosapentaenoic acid effect on hyperlipidemia in menopausal Japanese women. The Niigata Epadel Study Group","volume":"96","author":"Kurabayashi","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacl.2011.10.018_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2337\/dc06-1179","article-title":"Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome","volume":"30","author":"Satoh","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2011.10.018_bib30","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/STROKEAHA.107.509455","article-title":"Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial","volume":"39","author":"Tanaka","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jacl.2011.10.018_bib31","first-page":"765","article-title":"Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels","volume":"50","author":"Agren","year":"1996","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib32","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1093\/jn\/126.12.3032","article-title":"Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects","volume":"126","author":"Conquer","year":"1996","journal-title":"J Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0022-2275(20)33890-6","article-title":"Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background","volume":"39","author":"Conquer","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2011.10.018_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/07315724.1997.10718680","article-title":"Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Davidson","year":"1997","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.5414\/CPP42672","article-title":"Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study","volume":"42","author":"Engler","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jacl.2011.10.018_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1079\/BJN20051720","article-title":"Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial","volume":"95","author":"Geppert","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/86.2.324","article-title":"Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men","volume":"86","author":"Kelley","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/07315724.2005.10719465","article-title":"Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol","volume":"24","author":"Maki","year":"2005","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1079\/BJN20051658","article-title":"Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6 n-3) and docosapentaenoic acid (22:5 n-6) on cardiovascular risk factors in healthy men and women","volume":"95","author":"Sanders","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ajcn\/79.5.765","article-title":"Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy","volume":"79","author":"Stark","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ajcn\/79.4.558","article-title":"LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women","volume":"79","author":"Theobald","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.ejcn.1602328","article-title":"Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in\u00a0vivo oxidative stress in postmenopausal vegetarian women","volume":"60","author":"Wu","year":"2006","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2008.10.024","article-title":"Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart risk","volume":"53","author":"Robinson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2011.10.018_bib44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.jacl.2011.10.018_bib45","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.97.10.946","article-title":"Cholesterol reduction yields clinical benefit: impact of statin trials","volume":"97","author":"Gould","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2011.10.018_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High density lipoprotein cholesterol and cardiovascular disease: four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2011.10.018_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.mco.0000214566.67439.58","article-title":"The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans","volume":"9","author":"Mori","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jacl.2011.10.018_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MJT.0b013e31817fe2be","article-title":"Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors","volume":"16","author":"Ryan","year":"2009","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacl.2011.10.018_bib49","first-page":"A20007","article-title":"Effects of eicosapentaenoic acid, docosahexaenoic acid, and olive oil on cardiovascular disease risk factors [abstract 20007]","volume":"122","author":"Schaefer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2011.10.018_bib50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/14779072.6.3.391","article-title":"Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacl.2011.10.018_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0955-2863(98)00094-1","article-title":"Omega-3 fatty acids alter lipoprotein subfraction distributions and the in\u00a0vitro conversion of very low density lipoproteins to low density lipoproteins","volume":"10","author":"Lu","year":"1999","journal-title":"J Nutr Biochem"},{"issue":"Pt 1","key":"10.1016\/j.jacl.2011.10.018_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/0264-6021:3430191","article-title":"In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation","volume":"343","author":"Berge","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.jacl.2011.10.018_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2011.10.018_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11745-001-0735-3","article-title":"Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells","volume":"36","author":"Hirano","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.jacl.2011.10.018_bib55","first-page":"256","article-title":"Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia","volume":"62","author":"Nozaki","year":"1992","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.jacl.2011.10.018_bib56","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.286.12.1468","article-title":"Low-density lipoprotein size, pravastatin treatment, and coronary events","volume":"286","author":"Campos","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2011.10.018_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"192","author":"Mora","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2011.10.018_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.1993.tb35704.x","article-title":"Effect of dietary fatty acids on LDL binding","volume":"683","author":"Hannah","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacl.2011.10.018_bib59","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-2275(20)41429-4","article-title":"Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells","volume":"33","author":"Lindsey","year":"1992","journal-title":"J Lipid Res"},{"issue":"Suppl","key":"10.1016\/j.jacl.2011.10.018_bib60","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1007\/BF02637050","article-title":"Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans","volume":"31","author":"Rambj\u00f8r","year":"1996","journal-title":"Lipids"},{"key":"10.1016\/j.jacl.2011.10.018_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-5793(87)80211-9","article-title":"The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rat","volume":"222","author":"Roach","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jacl.2011.10.018_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ajcn\/64.2.215","article-title":"Dietary fish oil decreases low-density-lipoprotein clearance in nonhuman primates","volume":"64","author":"Schectman","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2011.10.018_bib63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-2275(20)41546-9","article-title":"Dependence on dietary cholesterol for n-3 polyunsaturated fatty acid-induced changes in plasma cholesterol in the Syrian hamster","volume":"33","author":"Surette","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2011.10.018_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-2275(20)35196-8","article-title":"Specificity of lipid transfer protein for molecular species of cholesteryl ester","volume":"27","author":"Morton","year":"1986","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2011.10.018_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.nu.10.070190.001053","article-title":"Effects of N-3 fatty acids on lipid metabolism","volume":"10","author":"Nestel","year":"1990","journal-title":"Ann Rev Nutr"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287411007458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287411007458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T20:30:49Z","timestamp":1639513849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287411007458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1933287411007458"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2011.10.018","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}